Quality of life, disability and antipsychotics-related side effects in schizophrenia spectrum and bipolar disorder: the role of patient-reported outcome measures
作者:Sofia Francesca Aprile, Alessandro Rodolico, Sabrina Castellano, Pierfelice Cutrufelli, Antonio Di Francesco, Stefan Leucht, Filippo Caraci, Andrea Fiorillo, Maria Salvina Signorelli · 发表于:European Archives of Psychiatry and Clinical Neuroscience · 年份:2025 · DOI:10.1007/s00406-025-02169-8 · 被引用次数:2 · 研究领域:Schizophrenia research and treatment、Bipolar Disorder and Treatment、Treatment of Major Depression
BACKGROUND: Schizophrenia and bipolar disorder significantly impair daily functioning and quality of life. Effective treatment monitoring requires tools assessing both clinical symptoms and everyday impairment. AIM: This cross-sectional study explored relationships between symptoms, side effects, and functioning using clinician-rated and patient-reported measures. We examined whether the Glasgow Antipsychotic Side-Effect Scale (GASS), a patient-reported outcome measure (PROM), is associated with disability and quality of life comparably to the clinician-administered Udvalg for Kliniske Undersøgelser (UKU) Side Effect Rating Scale. METHODS: We recruited 100 individuals with schizophrenia spectrum or bipolar disorders receiving antipsychotic treatment. Linear regressions and network analyses were conducted. Linear regressions assessed the association between side effects, disability (World Health Organization Disability Assessment Schedule, WHODAS) and quality of life (EuroQol 5-Dimension scale, EQ-5D). Network analyses were conducted to explore the interplay between side effects, disability, quality of life and symptoms, the latter assessed using the Positive and Negative Syndrome Scale (PANSS), Young Mania Rating Scale (YMRS), and Montgomery-Åsberg Depression Rating Scale (MADRS). RESULTS: Side effects assessed with GASS and UKU significantly impacted disability (GASS: p < .001, 95% CI [0.274; 0.635]; UKU: p < .001, 95% CI [0.313; 1.021]) and reduced quality of life (GASS: p ...